Apostolos Papavasileiou

Statistics

Publications

Citations

768

H-Index

Active since

2016

Affiliations

Queen Mary University of London(Current)

University of Groningen

University of Sassari

Barts Health NHS Trust

Ospedale Eugenio Morelli

Apostolos Papavasileiou is an author at Queen Mary University of London specializing in pharmacotherapy, multidrug-resistant tuberculosis treatment, and tuberculosis drug resistance.

ORCID

Publications per year

2016–2024

Publications

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu et al. · European Respiratory Journal · 2016 · 100 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of effectiveness and safety of imipenem/clavulanate-<i>versus</i>meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

Simon Tiberi, Giovanni Sotgiu, Lia D’Ambrosio et al. · European Respiratory Journal · 2016 · 81 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

S Koirala, Borisov Se, Edvardas Danila et al. · Pulmonology · 2021 · 47 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

1–5 of 8